DMD and Duchenne muscular dystrophy: Moreover, data regarding the functional aspects of the myocardium in dystrophin deficient tissues, the developmental effects of earlier VEGF administration, and the basal quantity of SCs following VEGF-induced angiogenesis in organisms lacking dystrophin all could help ready this therapy for clinical trials in DMD patients.